Targeting tumor-intrinsic hexosamine biosynthesis sensitizes pancreatic cancer to anti-PD1 therapy

Pancreatic ductal adenocarcinoma (PDAC) is considered to be a highly immunosuppressive and heterogenous neoplasm. Despite improved knowledge regarding the genetic background of the tumor and better understanding of the tumor microenvironment, immune checkpoint inhibitor therapy (targeting CTLA4, PD1...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Invest
Main Authors: Sharma, Nikita S., Gupta, Vineet K., Garrido, Vanessa T., Hadad, Roey, Durden, Brittany C., Kesh, Kousik, Giri, Bhuwan, Ferrantella, Anthony, Dudeja, Vikas, Saluja, Ashok, Banerjee, Sulagna
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Clinical Investigation 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6934212/
https://ncbi.nlm.nih.gov/pubmed/31613799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI127515
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados